Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Establishment and Characterization of a Novel Inducible Apoc2 and Cd36 double Knockout Mouse Model

Wenda Zhu, Yiting Meng, Xiaochen Zhang, Houda Alachkar

Blood (2024) 144 (Supplement 1): 5618.

https://doi.org/10.1182/blood-2024-211556

Published: 2024

Journal Articles

Temporal Analysis of T Cell Receptor Repertoire Dynamics in Acute Myeloid Leukemia (AML) Patients during Treatment and Disease Progression

Yiting Meng, Mateusz Pospiech, George Yaghmour, Abdullah Ladha, Houda Alachkar

Blood (2024) 144 (Supplement 1): 6156.

https://doi.org/10.1182/blood-2024-211462

Published: 2024

Journal Articles

Metabolomic Profiling of Asparaginase-Induced Hepatotoxicity in Pediatric Acute Lymphoblastic Leukemia

Amani Alqahatni, Deepa Bhojwani, Houda Alachkar

Blood (2024) 144 (Supplement 1): 2845.

https://doi.org/10.1182/blood-2024-211306

Published: 2024

Journal Articles

Analysis of ASXL1 Mutated T Cells in Patients with Myeloid Malignancies

Eduardo Fernandez, Jesse Sanchez, Gangning Liang, Mateusz Pospiech, Hongtao Li, Zarko Manojlovic, Houda Alachkar, Casey L. O'Connell

Blood (2023) 142 (Supplement 1): 6453.

https://doi.org/10.1182/blood-2023-173451

Published: 2023

Journal Articles

Loss of Cd36 Expression Has Limited Impact on Mouse Normal Hematopoiesis

Ophelia Meng, Mateusz Pospiech, Ritu Chandwani, Atham Ali, George Yaghmour, Houda Alachkar

Blood (2022) 140 (Supplement 1): 11395–11396.

https://doi.org/10.1182/blood-2022-171125

Published: 2022

Journal Articles

Gene Expression Patterns and Functional Characterization of CD36 in Normal Hematopoietic Cells

Ophelia Meng, Yang Zhao, George Yaghmour, Houda Alachkar

Blood (2021) 138 (Supplement 1): 4293.

https://doi.org/10.1182/blood-2021-154188

Published: 2021

Journal Articles

Development of Anti-CD99scFvs for the Treatment of Acute Myeloid Leukemia

Yang Zhao, Jiawei Li, Vijaya Pooja Vaikari, Albert Lam, Atham Ali, Ophelia Meng, George Yaghmour, Yong Zhang, Houda Alachkar

Blood (2021) 138 (Supplement 1): 4345.

https://doi.org/10.1182/blood-2021-154304

Published: 2021

Journal Articles

Outcomes of COVID-19 in Hematopoietic Stem-Cell Transplant Recipients: A Single Institution Observational Study

Sami Dwabe, Lakshmi Savitala-Damerla, Jack Rodman, Abdullah Ladha, Eric Tam, Houda Alachkar, Karrune Woan, Preet M. Chaudhary, George Yaghmour

Blood (2021) 138 (Supplement 1): 4896.

https://doi.org/10.1182/blood-2021-149204

Published: 2021

Journal Articles

Asparaginase Induced Liver Enzyme Elevation Is More Prevalent in Hispanics Children with ALL and in Patients with SOD2 rs4880 CC Genotype

Sharon Wu, Mengxi Wang, Amani Ali Alqahatni, Mimi Lou, Wendy Stock, Deepa Bhojwani, Houda Alachkar

Blood (2021) 138 (Supplement 1): 2279.

https://doi.org/10.1182/blood-2021-154268

Published: 2021

Journal Articles

Development of T Cell Receptor Analysis Based Strategy to Identify Leukemia Specific Neoantigens

Lucas Gutierrez, BS, Jason Giles, MS, Miran Jang, PhD, Mojtaba Akhtari, MD, Ian Haworth, PhD, Houda Alachkar, PharmD, PhD

Blood (2018) 132 (Supplement 1): 4549.

https://doi.org/10.1182/blood-2018-99-120365

Published: 2018

Journal Articles

Functional Analysis of CD99 Upregulation in Acute Myeloid Leukemia

Vijaya Pooja Vaikari, MS, Jiawen Yang, BS, Mojtaba Akhtari, MD, Houda Alachkar, PharmD, PhD

Blood (2018) 132 (Supplement 1): 5129.

https://doi.org/10.1182/blood-2018-99-120348

Published: 2018

Journal Articles

CD97 Is Associated with Poor Overall Survival in Acute Myeloid Leukemia

Vijaya Pooja Vaikari, MS, Sharon Wu, BS, Houda Alachkar, PharmD, PhD

Blood (2018) 132 (Supplement 1): 2794.

https://doi.org/10.1182/blood-2018-99-120324

Published: 2018

Journal Articles

Characterization of Upregulated Adhesion GPCRs in Acute Myeloid Leukemia

Jiawen Yang, BS, Sharon Wu, BS, Houda Alachkar, PharmD, PhD

Blood (2018) 132 (Supplement 1): 1515.

https://doi.org/10.1182/blood-2018-99-119998

Published: 2018

Journal Articles

Characterization of Mutations in the Mitochondrial Encoded Electron Transport Chain Complexes in Acute Myeloid Leukemia

Sharon Wu, BS, Mojtaba Akhtari, MD, Houda Alachkar, PharmD, PhD

Blood (2018) 132 (Supplement 1): 1477.

https://doi.org/10.1182/blood-2018-99-120001

Published: 2018

Journal Articles

Interaction between FLT3 and CD99 in Acute Myeloid Leukemia

Vijaya Pooja Vaikari, MS, Sharon Wu, BS, Tian Zhang, BS, Sasha Kartman, Manal Abdi, Klaus H. Metzeler, MD, Mojtaba Akhtari, MD, Houda Alachkar, PharmD, PhD

Blood (2017) 130 (Supplement 1): 3786.

https://doi.org/10.1182/blood.V130.Suppl_1.3786.3786

Published: 2017

Journal Articles

APOC2 Is Upregulated in Acute Myeloid Leukemia and Presents a Novel Therapeutic Target

Tian Zhang, BS, Vijaya Pooja Vaikari, MS, Sharon Wu, BS, Donna Alexandra Loza, Mojtaba Akhtari, MD, Houda Alachkar, PharmD, PhD

Blood (2017) 130 (Supplement 1): 2483.

https://doi.org/10.1182/blood.V130.Suppl_1.2483.2483

Published: 2017

Journal Articles

Inhibition of FLT3-ITD and Melk By Small Molecule Inhibitor OTS167 in FLT3 mutant Acute Myeloid Leukemia (AML)

Bartholomew Eisfelder, PhD, Houda Alachkar, PharmD, PhD, Margaret Colton, Noreen Fulton, BS, Olatoyosi Odenike, MD, Yusuke Nakamura, MD, Wendy Stock, MD

Blood (2017) 130 (Supplement 1): 2525.

https://doi.org/10.1182/blood.V130.Suppl_1.2525.2525

Published: 2017

Journal Articles

Midostaurin Reduces Regulatory T Cell Population in Healthy and Acute Myeloid Leukemia Cells

Lucas Gutierrez, BS, Tian Zhang, BS, Miran Jang, PhD, Mojtaba Akhtari, MD, Houda Alachkar, PharmD, PhD

Blood (2017) 130 (Supplement 1): 2621.

https://doi.org/10.1182/blood.V130.Suppl_1.2621.2621

Published: 2017

Journal Articles

CD99 Is Highly Expressed in Acute Myeloid Leukemia (AML) and Presents a Viable Therapeutic Target

Vijaya Pooja Vaikari, MS, Miran Jang, PhD, Mojtaba Akhtari, MD, Houda Alachkar, PhD PharmD

Blood (2016) 128 (22): 1540.

https://doi.org/10.1182/blood.V128.22.1540.1540

Published: 2016

Journal Articles

Characterization of Tcra and Tcrb Repertoires in Acute Myeloid Leukemia Patients before and after Combined Haploidentical and Umbilical Cord Blood Transplant

Houda Alachkar, PharmD, PhD, Poh-Yin Yew, PhD, Rui Yamaguch, Kazuma Kiyotani, Hongtao Liu, MDPhD, Andrew S. Artz, MD MS, Amittha Wickrema, PhD, Koen van Besien, MD, Michael R Bishop, MD, Satoru Miyano, PhD, Wendy Stock, MD, Yusuke Nakamura, MD PhD

Blood (2014) 124 (21): 2503.

https://doi.org/10.1182/blood.V124.21.2503.2503

Published: 2014

NARROW

Establishment and Characterization of a Novel Inducible Apoc2 and Cd36 double Knockout Mouse Model

Temporal Analysis of T Cell Receptor Repertoire Dynamics in Acute Myeloid Leukemia (AML) Patients during Treatment and Disease Progression

Metabolomic Profiling of Asparaginase-Induced Hepatotoxicity in Pediatric Acute Lymphoblastic Leukemia

Analysis of ASXL1 Mutated T Cells in Patients with Myeloid Malignancies

Loss of Cd36 Expression Has Limited Impact on Mouse Normal Hematopoiesis

Gene Expression Patterns and Functional Characterization of CD36 in Normal Hematopoietic Cells

Development of Anti-CD99scFvs for the Treatment of Acute Myeloid Leukemia

Outcomes of COVID-19 in Hematopoietic Stem-Cell Transplant Recipients: A Single Institution Observational Study

Asparaginase Induced Liver Enzyme Elevation Is More Prevalent in Hispanics Children with ALL and in Patients with SOD2 rs4880 CC Genotype

Development of T Cell Receptor Analysis Based Strategy to Identify Leukemia Specific Neoantigens

Functional Analysis of CD99 Upregulation in Acute Myeloid Leukemia

CD97 Is Associated with Poor Overall Survival in Acute Myeloid Leukemia

Characterization of Upregulated Adhesion GPCRs in Acute Myeloid Leukemia

Characterization of Mutations in the Mitochondrial Encoded Electron Transport Chain Complexes in Acute Myeloid Leukemia

Interaction between FLT3 and CD99 in Acute Myeloid Leukemia

APOC2 Is Upregulated in Acute Myeloid Leukemia and Presents a Novel Therapeutic Target

Inhibition of FLT3-ITD and Melk By Small Molecule Inhibitor OTS167 in FLT3 mutant Acute Myeloid Leukemia (AML)

Midostaurin Reduces Regulatory T Cell Population in Healthy and Acute Myeloid Leukemia Cells

CD99 Is Highly Expressed in Acute Myeloid Leukemia (AML) and Presents a Viable Therapeutic Target

Characterization of Tcra and Tcrb Repertoires in Acute Myeloid Leukemia Patients before and after Combined Haploidentical and Umbilical Cord Blood Transplant

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only